Get the latest tech news

FDA clears blood test to aid evaluation for Alzheimer's disease


The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.

None

Get the Android app

Or read this on Hacker News

Read more on:

Photo of FDA

FDA

Photo of alzheimer

alzheimer

Photo of disease

disease

Related news:

News photo

Meet Aletta: The first FDA approved robotic blood draw device

News photo

FDA approves robot that can find your vein, insert a needle, and draw blood without human help

News photo

Putting money where their mouth is: Anthropic’s Claude autonomously designs disease-targeting proteins with real wet-lab proof, hitting a 35% success rate vs 10–15% human average